MDBZ, also known as 3,4-methylenedioxy-N-benzylamphetamine or as N-benzyl-MDA, is a chemical compound of the phenethylamine, amphetamine, MDxx, and N-benzylphenethylamine families related to MDA. It is the N-benzyl derivative of MDA.
In his book PiHKAL (Phenethylamines I Have Known and Loved), Alexander Shulgin lists MDBZ's dose as greater than 150mg orally and its duration as unknown. According to Shulgin, MDBZ showed "little if any activity".
The chemical synthesis of MDBZ has been described.
Analogues of MDBZ include MDA, MDMA, MDCPM, benzphetamine, benzylone (bk-MDBZ), and 2C2-NBOMe, among others.
MDBZ was first described in the scientific literature by Alexander Shulgin and colleagues in 1980. Subsequently, it was described in greater detail by Shulgin in his book PiHKAL (Phenethylamines I Have Known and Loved) in 1991.
In an episode of the British spoof documentary TV show Brass Eye, David Amess MP was fooled into recording a warning against a fictitious new drug called "cake". When asked a parliamentary question about it, the Home Office incorrectly assumed Amess was referring to MDBZ.
MDBZ is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.